Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

AMRN, ARRY, PRQR, XLNX

Published 11/15/2018, 11:18 PM
Updated 07/09/2023, 06:31 AM

Amarin Corporation (NASDAQ:AMRN), which was obviously a buy for us at the 10 level back in September, ran up to both of the targets, but I was looking for more, 27 to be exact. It hit 23.34, rolled over and went down 10 points to 13.56. In the last two days it has jumped from 13.56 to 19.20, almost 6 points, or 45%. The volume was decent but not heavy, and the underlying technicals were just okay. On Thursday, this stock closed up 1.60, or 10%, to 17.72, on 23.5 million shares. What I’m worried about is that the pullback and reversal right near the support level and technical bounce-back. Right now, it looks like resistance is at 19.98. I need this to get through the 20 level, before it can make a run at 23 and 27 targets. Keep close tabs on it. I still like the overall look of it.

Array BioPharma Inc. (NASDAQ:ARRY), which we gave you as a swing, ran up and pulled back hard when the market did, and then reversed nicely with a big engulfing bar on Thursday, jumping 1.18, or 8%, to 15.71, on 2.7 million shares. That’s the best volume in 5-6 sessions. It needs to get a follow-through because Thursday’s high at 15.93 is where there’s resistance. First, it needs to retest the highs at 17 1/2-18, then head to 20.

ProQR Therapeutics N.V. (NASDAQ:PRQR) looks good. It popped out of a falling wedge or flag, gaining 1.73, or 10%, to 19.48, on 871,094 shares traded. That was the best volume in two months. I’m still looking for this to make a move to 22 1/2-23 zone, and then 27 1/2-3/4.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Swing trade Xilinx, Inc. (NASDAQ:XLNX) is doing great. After the wedge formed this last week, it got very quiet on lower volume on Thursday, and then boom, it went straight up, popping 4.72, or 5.6%, to 88.51, on 3.7 million share. The long-term channel target says it’s headed to 92-93.

Stocks on the long side included Amarin Corporation plc (AMRN), Array BioPharma Inc. (ARRY), CareDx, Inc (CDNA), Denali Therapeutics Inc. (DNLI), Kornit Digital Ltd. (KRNT), Lannett Company, Inc. (LCI), New Age Beverages Corporation (NBEV), ProQR Therapeutics N.V. (PRQR), uniQure N.V. (QURE), Twilio Inc. (TWLO), Vanda Pharmaceuticals Inc. (VNDA), 21Vianet Group, Inc. (VNET), and Xilinx, Inc. (XLNX).

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.